Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Vertex Pharmaceuticals Inc
SWB:VX1
Vertex Pharmaceuticals Inc
SWB:VX1
Price:
408.05
EUR
-1.79%
Market Cap:
€48.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Vertex Pharmaceuticals Inc
SWB:VX1
|
US |
|
M
|
Medpace Holdings Inc
F:01P
|
US |
Wall St Price Targets
VX1 Price Forecast
Based on 29 analysts
Based on 29 analysts
+24% Upside
from
€408.05
today
Vertex Pharmaceuticals Inc (VX1)’s 12-month stock price forecast through August 2027 has a consensus target of €506.26, implying 24% upside. The forecast is based on price targets from 29 Wall Street analysts.
VX1 Analyst Rating
No ratings yet
No ratings yet
Vertex Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
506.26
EUR
506.26
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 506.26 EUR with a low forecast of 303.82 EUR and a high forecast of 606.43 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
21%
21%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
14%
14%
The compound annual growth rate for Net Income over the next 8 years is 14%.